Status:
COMPLETED
An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice
Lead Sponsor:
Biogen
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Brief Summary
The primary objective of the study is to collect additional safety data including the incidence rate of seizure and other specific Adverse Events (AEs) of interest from participants taking Fampyra in ...
Eligibility Criteria
Inclusion
- Key
- MS patients with any disease subtype who are ≥18 years of age and must have been newly prescribed Fampyra but not yet started the treatment.
- Patients who are willing and able to provide written informed consent.
- Key
Exclusion
- None
- NOTE: Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
April 16 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 8 2019
Estimated Enrollment :
4734 Patients enrolled
Trial Details
Trial ID
NCT01480063
Start Date
April 16 2012
End Date
February 8 2019
Last Update
June 5 2019
Active Locations (164)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Ciudad Autonoma de Buanos Aires, Buenos Aires, Argentina
2
Research Site
Rosario, Santa Fe Province, Argentina
3
Research Site
Buenos Aires, Argentina, C10161ABD
4
Research Site
Córdoba, Argentina